Herbs (Global Traditional) · Southeast Asian
Sandalwood (Santalum album) (Santalum album)
Moderate Evidencebotanical4 PubMed Studies
Hermetica Superfood Encyclopedia
Sandalwood (Santalum album) contains sesquiterpene compounds including alpha-santalol and beta-santalol as primary bioactives. Currently no documented clinical health benefits exist, with research limited to extraction methods and chemical composition analysis.
Santalum album, commonly known as Indian sandalwood, is a small evergreen tree native to southern India, Indonesia, and Australia, valued for the essential oil extracted from its mature heartwood. The oil is obtained through various methods including steam hydrodistillation, solvent extraction, and supercritical CO₂ extraction, yielding 2.6-5.0% volatile oil content.
No human clinical trials, RCTs, or meta-analyses on Santalum album were identified in the research. The only cited study (PMID 22428257) focuses on chemical composition analysis rather than therapeutic outcomes. All available research emphasizes extraction methods and compound identification through analytical chemistry techniques.
No clinically studied dosage ranges have been established for Santalum album extracts, powders, or standardized forms. Extraction yields of 2.6-5.0% volatile oil are reported for analytical purposes only, without human dosing data. Consult a healthcare provider before starting any new supplement.
Sandalwood (Santalum album) is not consumed as a food and therefore lacks a conventional nutritional profile (macronutrients, vitamins, minerals, dietary fiber, etc.). Its significance lies entirely in its bioactive volatile and non-volatile chemical constituents, primarily extracted from heartwood and roots via steam distillation. Key bioactive compounds include: • **α-Santalol** (~45–55% of essential oil): the principal sesquiterpene alcohol; responsible for most documented biological activity; exhibits anti-inflammatory, antimicrobial, and potential chemopreventive properties in preclinical models. • **β-Santalol** (~18–24% of essential oil): a secondary sesquiterpene alcohol with complementary bioactivity to α-santalol; studied for anti-proliferative effects in vitro. • **epi-β-Santalol** (~3–6%): minor sesquiterpene contributing to overall oil composition. • **α-Bergamotol** (~3–5%): sesquiterpene alcohol contributing to aromatic and potential bioactive profile. • **Santalenes (α- and β-)** (~5–10% combined): sesquiterpene hydrocarbons serving as biosynthetic precursors to santalols. • **trans-β-Santalol and cis-lanceol**: minor constituents (~1–3%) identified via GC-MS (PMID 22428257). • **Santalic acid and tetrahydrosantalic acid**: trace non-volatile compounds found in heartwood extracts. • **Polyphenolic compounds**: minimal quantities reported in aqueous/ethanolic bark extracts, with low antioxidant capacity relative to dietary polyphenol sources. Overall essential oil yield from mature heartwood is approximately 3–7% (w/w). No meaningful amounts of proteins, carbohydrates, fats, vitamins (A, C, E, B-complex), or dietary minerals (Ca, Fe, Zn, Mg) are present in forms relevant to human nutrition. Bioavailability of sesquiterpene alcohols is primarily studied via dermal absorption and inhalation routes rather than oral ingestion; α-santalol demonstrates significant percutaneous absorption (~10–15% in in vitro skin models) but oral pharmacokinetics in humans remain poorly characterized. The material is classified as an aromatic/medicinal plant product, not a food or nutritional supplement.
Sandalwood's sesquiterpene compounds alpha-santalol and beta-santalol represent the primary bioactive constituents. However, specific molecular pathways, receptor interactions, and enzymatic mechanisms remain undocumented in clinical literature. Research has focused exclusively on chemical identification rather than therapeutic mechanisms.
No clinical trials have evaluated sandalwood's health benefits in humans. Available research consists primarily of chemical composition studies identifying sesquiterpene content through analytical methods. One study (PMID 22428257) characterized molecular components but provided no therapeutic outcomes. Evidence strength remains insufficient for any health claims.
Safety profile remains undetermined due to lack of clinical research on sandalwood supplementation. Post-distillation extracts show reduced allergen content compared to raw material, suggesting potential for skin sensitization. Drug interactions and contraindications have not been systematically studied. Pregnancy and lactation safety data are unavailable.
